Sign up Australia
Proactive Investors - Run By Investors For Investors

Holista CollTech to gain European bakery expert as shareholder

Holista CollTech to gain European bakery expert as shareholder

Holista Colltech (ASX:HCT) will issue shares up to a 10% stake to the major shareholder of Swiss Panadoro Group and Matzingen-based Veripan AG, Europe’s largest independent supplier of specialty baking ingredients.

Holista, which recently announced a scientific breakthrough to make white bread healthier with its combination of a blend of okra, lentils, barley and fenugreek with Veripan’s sourdough formula to form PANATURA® GI, will sell shares and free attaching options to Meiert Grootes in tranches.

Grootes will acquire the shares at $0.115 amounting to A$454,734, via a direct placement, equal to a 2.5% holding.

Free attached options will be issued for 11,862,616 new shares, which will enlarge his stake in Holista by a further 7.5% exercisable at various strike prices.

Holista's patented formula scored a Glycemic Index (“GI”) reading of 53, the lowest-ever achieved by any clean-label white bread in a clinical trial.

It will begin marketing PANATURA® GI to the US$170 billion white bread market, a rollout in which Grootes will play a significant role given his 27 years’ experience in the bread industry and contacts in the milling and bakery industry.

Clearly, interesting times are ahead in the roll-out of the product.


Proactive Investors Australia is the market leader in producing news, articles and research reports on ASX emerging companies with distribution in Australia, UK, North America and Hong Kong / China.



Register here to be notified of future HCT Company articles
View full HCT profile

Holista Colltech Timeline

Related Articles

Genetic data
July 12 2016
Drug discovery company snaps up software system for "non-material" sum
picture of pregnant woman
February 07 2017
MyLotus has been developed for women who have been trying to conceive for six months or more.
Stem Cells
March 31 2017
WideCells is aiming to be a major supporting player through its development of a stem cell storage business and, having only listed in London last July, its newsflow so far looks to be pointing the way

© Proactive Investors 2017

Proactive Investors Australia PTY LTD ACN:132787654 ABN:19132787654.

Market Indices, Commodities and Regulatory News Headlines copyright © Morningstar. Data delayed 15 minutes unless otherwise indicated. Terms of use